Formulations of Bendamustine | Patent Publication Number 20230115693
US 20230115693 A1Patent NumberUS 11872214 B2
Application Number18081251
Filled DateDec 14, 2022
Priority DateJan 28, 2010
Publication DateApr 13, 2023
Original AssigneeEagle Pharmaceuticals Inc.
Current AssigneeEagle Pharmaceuticals Inc.
Inventor/ApplicantsNagesh R. Palepu
Philip Christopher Buxton
Philip Christopher Buxton
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.